Lisdexamfetamine Impurity 34 - Request Quote
Lisdexamfetamine Impurity 34
| SZ CAT No: | SZ-L092052 |
| CAS No | NA |
| Mol.F. | C9H13N : CH4O3S |
| Mol.Wt. |
135.2 : 96.1 |
| Inv. Status |
Synthesis on demand |
| Rel. CAS No | 51-64-9 (free base) |
Additional Documents Required to PurchaseChemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lisdexamfetamine Impurity 34 is chemically (S)-1-phenylpropan-2-amine methanesulfonate. Lisdexamfetamine Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Lisdexamfetamine Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lisdexamfetamine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Lisdexamfetamine Impurity 34
Purchase Lisdexamfetamine Impurity 34
Lisdexamfetamine Impurity 34 suppliers
Lisdexamfetamine Impurity 34 manufacturers
Lisdexamfetamine Impurity 34 price
Order Lisdexamfetamine Impurity 34
Enquire Lisdexamfetamine Impurity 34
Lisdexamfetamine Impurity 34 cost
Lisdexamfetamine Impurity 34 Supplier
Lisdexamfetamine Impurity 34 Distributor
Lisdexamfetamine Impurity 34 for Method Validation
Lisdexamfetamine Reference Standard
Lisdexamfetamine Impurity 34 for ANDA Filing
Lisdexamfetamine Impurity 34 for Forced Degradation Studies
Lisdexamfetamine Impurity 34 Identification Standards
Lisdexamfetamine Impurity 34 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.